Note that spending totals are estimates generated by comparing previous government data figures from Medicaids State Drug Utilization Database to real-time claims data
Medications that mimic GLP-1 (like semaglutide and tirzepatide) are FDA-approved for: Type 2 diabetes management (Ozempic) Chronic weight management (Wegovy, Zepbound, and Mounjaro) These drugs help reduce appetite, slow digestion, and improve metabolic efficiencyall of which support gradual, sustainable weight loss
Anderberg RH, Richard JE, Eerola K, Ferreras LL, Nordbeck EB, Hansson C, et al
Expiration Date 05/01/2027 00:00:00 UPC 817598000714 Ingredients Delayed release capsule (hypromellose, gellan gum), microcrystalline cellulose, vegetable magnesium stearate, silicon dioxide
Clin Pharmacol Ther 1989;45:234-40
Sections were blocked with 5% donkey serum in 0.1% NP-40/PBS at room temperature for 1 hour